NasdaqGS - Nasdaq Real Time Price USD
Embecta Corp. (EMBC)
12.73
+0.45
+(3.66%)
At close: May 2 at 4:00:00 PM EDT
12.73
0.00
(0.00%)
After hours: May 2 at 4:05:11 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Devdatt Kurdikar Ph.D. | President, CEO & Director | 2.34M | -- | 1969 |
| Mr. Jacob P. Elguicze | Senior VP & CFO | 1.12M | -- | 1973 |
| Mr. Jeffrey Z. Mann | Senior VP, General Counsel, Head of Business Development & Corporate Secretary | 993.2k | -- | 1972 |
| Ms. Jean M. Casner | Senior VP & Chief Human Resources Officer | 811.22k | -- | 1958 |
| Mr. Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain | 1.03M | -- | 1970 |
| Mr. Anthony M. Roth | VP, Chief Accounting Officer & Corporate Controller | -- | -- | 1973 |
| Ms. Colleen Riley | Senior VP & Chief Technology Officer | -- | -- | 1965 |
| Mr. Pravesh Khandelwal | VP & Head of Investor Relations | -- | -- | -- |
| Ms. Ginny Blocki | Senior Vice President of Global Marketing & Product Management | -- | -- | -- |
| Mr. Tom Blount | Senior VP & President of North America | -- | -- | 1974 |
Embecta Corp.
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
- Full Time Employees:
- 2,100
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Corporate Governance
Embecta Corp.’s ISS Governance QualityScore as of May 1, 2025 is 2. The pillar scores are Audit: 9; Board: 2; Shareholder Rights: 2; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 9, 2025 at 12:30 PM UTC
Embecta Corp. Earnings Date
Recent Events
March 14, 2025 at 12:00 AM UTC
Dividend Date
February 28, 2025 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
UTMD Utah Medical Products, Inc.
52.66
+0.88%
KMTS Kestra Medical Technologies, Ltd. Common Stock
23.75
+3.44%
ANGO AngioDynamics, Inc.
9.29
+1.09%
AZTA Azenta, Inc.
26.96
+2.78%
XRAY DENTSPLY SIRONA Inc.
14.08
+1.08%
STVN Stevanato Group S.p.A.
21.38
+3.09%
ALC Alcon Inc.
98.30
+2.21%
CLPBY Coloplast A/S
10.55
-2.31%
NVST Envista Holdings Corporation
16.99
+3.98%
ATR AptarGroup, Inc.
152.00
+2.51%